Erratum to epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer
Erratum

Erratum to epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer

Editorial Office

Annals of Translational Medicine

Correspondence to: Editorial Office. Annals of Translational Medicine. Email: editor@atmjournal.org.

Submitted Jul 21, 2022. Accepted for publication Aug 04, 2022.

doi: 10.21037/atm-2022-48


Erratum to: Ann Transl Med 2019;7:723

This article (1) titled “Epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer” (doi: 10.21037/atm.2019.12.23), unfortunately contains an error in Figure 4. Specifically, data from soft agar and transwell experiments in Figure 4 was presented incorrect accidentally, which is from another project. The correct Figure 4 can be found below.

Corrected Figure 4:

The authors apologize for the oversight.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Li W, Zheng X, Ren L, et al. Epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer. Ann Transl Med 2019;7:723. [Crossref] [PubMed]
Cite this article as: Editorial Office. Erratum to epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer. Ann Transl Med 2022;10(18):1042. doi: 10.21037/atm-2022-48

Download Citation